GlassScriptPhysician profile
Ewa H Konca
NPI 1134197528
$55,254.54
in general payments reported to CMS, 2019-2025
59 companies · $2,870 in 2025
The $2,870 reported for 2025 was more than what 82% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $10K · 2021: $7,899 · 2022: $11K · 2023: $2,151 · 2024: $925 · 2025: $2,870.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,946.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,946.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $20,471.62 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $12,604.52 | 2019-2020 | |
| Lilly USA, LLC | $9,745.37 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $1,699.82 | 2019-2025 | Tepezza, Evenity, Repatha |
| Novo Nordisk INC | $1,047.86 | 2020-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $867.67 | 2019-2023 | Farxiga |
| Abbott Laboratories | $790.84 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Dexcom, INC. | $740.13 | 2019-2025 | Dexcom G6 Transmitter |
| Radius Health, INC. | $705.69 | 2019-2025 | Tymlos |
| Medtronic, INC. | $679.47 | 2021-2023 | Minimed 780g, Minimed 770g |
| Boehringer Ingelheim Pharmaceuticals, INC. | $505.18 | 2019-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $499.11 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $389.28 | 2022-2025 | |
| Mannkind Corporation | $373.03 | 2019-2023 | Afrezza |
| Xeris Pharmaceuticals, INC. | $341.91 | 2021-2025 | Gvoke Hypopen, Recorlev |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $283.15 | 2019-2022 | |
| Ibsa Pharma INC. | $255.77 | 2019-2022 | |
| Verity Pharmaceuticals INC. | $254.05 | 2025 | Tlando |
| Abbvie INC. | $236.20 | 2019-2025 | |
| Corcept Therapeutics | $224.32 | 2019-2024 | Korlym |
| Pfizer INC. | $219.93 | 2019-2025 | |
| Insulet Corporation | $212.92 | 2019-2024 | Omnipod |
| Horizon Therapeutics Plc | $205.65 | 2021-2023 | Tepezza |
| Medtronic Minimed, INC. | $184.51 | 2019-2020 | |
| Recordati_rare_diseases_inc. | $156.45 | 2021-2025 | Isturisa, Signifor Lar |
| Beta Bionics, INC. | $98.89 | 2024 | Ilet Bionic Pancreas |
| Regeneron Healthcare Solutions, INC. | $91.87 | 2019-2020 | |
| Ascendis Pharma Endocrinology INC | $83.22 | 2024-2025 | Yorvipath |
| Rhythm Pharmaceuticals, INC. | $78.49 | 2021-2025 | Imcivree |
| Esperion Therapeutics, INC. | $72.96 | 2020-2025 | Nexletol |
| Kyowa Kirin, INC. | $72.07 | 2023-2025 | Crysvita |
| Neurocrine Biosciences, INC. | $66.67 | 2025 | |
| Ionis Pharmaceuticals, INC. | $66.49 | 2025 | Tryngolza |
| Boston Scientific Corporation | $65.01 | 2025 | General - Pain Management |
| Tandem Diabetes Care, INC. | $63.68 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Ultragenyx Pharmaceutical INC. | $56.31 | 2021-2023 | Crysvita |
| Sequel Med Tech, LLC | $51.71 | 2025 | Twiist |
| Alexion Pharmaceuticals, INC. | $50.54 | 2019-2022 | |
| Amryt Pharma Holdings LTD | $50.13 | 2022-2023 | Mycapssa |
| Chiesi USA, INC. | $46.62 | 2025 | Mycapssa, Myalept |
| Lifescan, INC. | $45.78 | 2020-2022 | |
| Alvogen INC | $45.46 | 2023 | Teriparatide |
| Amarin Pharma, INC. | $43.82 | 2020 | |
| Vistapharm, INC. | $42.80 | 2021 | |
| Bigfoot Biomedical INC | $41.65 | 2022 | |
| Averitas Pharma INC. | $41.21 | 2025 | Qutenza |
| Embecta Corp. | $38.01 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Amneal Pharmaceuticals LLC | $28.57 | 2019 | |
| Inspire Medical Systems, INC. | $28.26 | 2025 | Inspire |
| Madrigal Pharmaceuticals | $25.13 | 2025 | Rezdiffra |
| Exact Sciences Corporation | $24.13 | 2025 | The Cologuard Plus Collection Kit |
| Ipsen Biopharmaceuticals, INC | $23.29 | 2019 | |
| Shire North American Group INC | $21.90 | 2019 | |
| Astellas Pharma US INC | $21.65 | 2023 | Veozah |
| Janssen Scientific Affairs, LLC | $20.61 | 2019 | |
| Glaxosmithkline, LLC. | $19.27 | 2025 | Arexvy, Shingrix |
| Acella Pharmaceuticals, LLC | $16.28 | 2024 | NP Thyroid 60 |
| Venclose INC. | $10.24 | 2020 | |
| Bard Peripheral Vascular, INC. | $7.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ewa Konca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.